Similar articles for PMID: 19564276

Year	Number of Results
1980	1
1981	1
1987	2
1996	2
1997	1
2000	2
2001	2
2002	2
2003	4
2004	9
2005	7
2006	25
2007	28
2008	57
2009	86
2010	6
2011	5
2012	5
2013	3
2014	10
2015	1
2016	3
2017	4
2018	2
2019	3
2020	5
2021	2

1

Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.

Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW. Son MB, et al. Pediatrics. 2009 Jul;124(1):1-8. doi: 10.1542/peds.2008-0730. Pediatrics. 2009. PMID: 19564276

2

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW. Son MB, et al. J Pediatr. 2011 Apr;158(4):644-649.e1. doi: 10.1016/j.jpeds.2010.10.012. Epub 2010 Dec 3. J Pediatr. 2011. PMID: 21129756 Clinical Trial.

3

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC. Tremoulet AH, et al. Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24. Lancet. 2014. PMID: 24572997 Clinical Trial.

4

Infliximab as a novel therapy for refractory Kawasaki disease.

Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Weiss JE, et al. J Rheumatol. 2004 Apr;31(4):808-10. J Rheumatol. 2004. PMID: 15088313

5

[Refractory Kawasaki disease with coronary aneurysms treated with infliximab].

Salguero JS, Durán DG, Peracaula CS, Iznardi CR, Tardío JO. Salguero JS, et al. An Pediatr (Barc). 2010 Nov;73(5):268-71. doi: 10.1016/j.anpedi.2010.06.006. Epub 2010 Aug 3. An Pediatr (Barc). 2010. PMID: 20678974 Free article. Spanish.

6

Kawasaki disease in a pediatric intensive care unit: a case-control study.

Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Dominguez SR, et al. Pediatrics. 2008 Oct;122(4):e786-90. doi: 10.1542/peds.2008-1275. Epub 2008 Sep 22. Pediatrics. 2008. PMID: 18809597

7

Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.

Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Furukawa T, et al. Arch Dis Child. 2008 Feb;93(2):142-6. doi: 10.1136/adc.2007.126144. Epub 2007 Oct 25. Arch Dis Child. 2008. PMID: 17962370

8

Clinical features of patients with Kawasaki disease whose parents had the same disease.

Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Uehara R, et al. Arch Pediatr Adolesc Med. 2004 Dec;158(12):1166-9. doi: 10.1001/archpedi.158.12.1166. Arch Pediatr Adolesc Med. 2004. PMID: 15583102

9

Infections and Kawasaki disease: implications for coronary artery outcome.

Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Benseler SM, et al. Pediatrics. 2005 Dec;116(6):e760-6. doi: 10.1542/peds.2005-0559. Pediatrics. 2005. PMID: 16322132

10

Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.

Dale RC, Saleem MA, Daw S, Dillon MJ. Dale RC, et al. J Pediatr. 2000 Nov;137(5):723-6. doi: 10.1067/mpd.2000.108444. J Pediatr. 2000. PMID: 11060542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed